Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Plasma Powder Industry?

In recent times, there has been a consistent expansion in the dimension of the plasma powder market. The market is projected to increase from a valuation of $3.04 billion in 2024 to $3.17 billion in 2025, displaying a compound annual growth rate (CAGR) of 4.3%. The historical growth has been fueled by factors such as developments in material science, a surge in surface alteration methods, a heightened demand for sophisticated coatings, growth in the semiconductor and electronics sector, and advancements in medical and biomedical fields.

The plasma powder industry is projected to witness robust expansion in the forthcoming years, with expectations to reach $3.96 billion by 2029 at a CAGR of 5.7%. Factors such as the fusion of nanotechnology, advancements in catalytic uses, its application in smart substances, its deployment in 3D printing, and the surge in demand in biomedical engineering are set to fuel growth in the prediction period. Notable trends during this period would involve plasma-polymer composite materials, hybrid additive manufacturing techniques, modifiable smart coverings, bioresorbable implants and films, along with plasma powder application in 5G tech.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12355&type=smp

#Which Factors Are Currently Driving The Growth Of The Plasma Powder Market?

Driven by an escalating requirement for premium-grade protein feeds, the plasma powder market is expected to witness substantial growth. Such increase in demand correlates with heightened consumption of top-tier feed by domesticated animals and pets. Plasma powder holds significance as a critical component, ensuring the feed is nutritious and beneficial for the animals. For example, based on American Feed Industry Association data from January 2022, there is a projection of about 2.5% annual growth in the U.S. animal feed market, potentially hitting approximately 254.6 million tons and valued around $48.8 billion by year 2025. Hence, the growing demand for high-quality protein feeds is fueling the expansion of the plasma powder market.

How Is The Global Plasma Powder Market Structured In Terms Of Segments?

The plasma powder market covered in this report is segmented –

1) By Source: Bovine, Porcine, Ovine, Other Sources

2) By Form: Dry, Wet

3) By Sales Channel: Online, Offline

4) By Application: Pet Food, Pig Feed, Poultry Feed, Aqua Feed, Ruminant Feed, Human Food, Other Applications

Subsegments:

1) By Bovine: Bovine Serum Powder, Bovine Plasma Protein

2) By Porcine: Porcine Serum Powder, Porcine Plasma Protein

3) By Ovine: Ovine Serum Powder, Ovine Plasma Protein

4) By Other Sources: Equine (Horse), Avian (Chicken), Other Animal Sources

What Trends Are Currently Influencing Growth In The Plasma Powder Market?

Major firms within the PD-1 and PDL1 inhibitor/immune checkpoint inhibitor sector are turning to strategic investments, such as the move by Regeneron Pharmaceuticals, Inc. to buy out Sanofi’s share of their mutual partnership on Libtayo (cemiplimab). This move granted exclusive global rights to Regeneron for the medication’s research, marketing, and production. The payment plan included a $900 million payment upfront, along with ongoing royalties and future milestone payments. To exemplify, in June 2022, U.S. based Regeneron Pharmaceuticals, Inc. shelled out $900 million to gain exclusive rights to develop, market, and manufacture the Libtayo (cemiplimab) globally. Developed using Regeneron’s exclusive VelocImmune technology, Libtayo is an entirely human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells. Approved by the U.S. Food and Drug Administration (FDA) and various regulatory bodies in over 24 countries, Libtayo is a cemiplimab-rwlc monotherapy treatment for select patients with advanced non-small cell lung cancer (NSCLC), both advanced cutaneous squamous cell carcinoma (CSCC) and advanced basal cell carcinoma (BCC). As a pioneering PD-1 inhibitor, Libtayo is employed in the treatment of approved non-melanoma skin cancers and is regarded as a standard of care. Sanofi S.A., the French pharmaceutical and healthcare firm was a part of the previous agreement.

Who Are The Main Participants Shaping The Plasma Powder Market Landscape?

Major companies operating in the plasma powder market include Takeda, CSL Behring, Darling Ingredients, Grifols, Octapharma, Kedrion, Valley Proteins Inc., Proliant Biologicals, Veos Group, Uruguayan Animal Proteins, Haripro SpA, Lihme Protein Solutions, Saria SE & Co. KG, Acontex GmbH, APC Inc., British Aqua Feeds, Feed Stimulants, Otto Chemie Pvt Ltd, Shenzhen Taier Biotechnology Co. Ltd, Animix LLC, Kraeber & Co GmbH, Rocky Mountain Biologicals

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-powder-global-market-report

Which Region Currently Holds The Largest Share In The Plasma Powder Market?

North America was the largest region in the plasma powder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma powder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12355&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model